Home Company Therapeutics Technology Partners Press room

Home / Therapeutics / GI Disease / Hepatobiliary



HEPATOBILIARY DISEASES


Clinical

Acute hepatic failure is a common cause of morbidity and mortality. The typical presentation is with encephalopathy (altered behaviour, progressing to coma) a few days after apparent recovery from a paracetamol (acetaminophen) overdose. Without a liver transplant, only 15% with coma survive. N-acetylcysteine and methionine decrease the incidence of hepatic failure in paracetamol overdose by replenishing cellular glutathione stores, although there is the need for additional hepatic protectants.

Chronic hepatitis, in which there is a chronic inflammatory cell infiltrate, is defined as any hepatitis lasting over 6 months. It is typically secondary to autoimmune disease, viral disease or drugs. This in turn may lead to necrosis of liver cells, followed by fibrosis and nodule formation – the cirrhotic liver. The commonest cause of cirrhosis in the Western world is alcoholism.


DanioLabs approach

DanioLabs is currently developing programmes for both acute and chronic liver disease.


Introduction
Neurology
Ophthalmology
Metabolic
GI Disease
      IBD
      IBS
      Hepatobiliary

 

 

 


GastroHep International Links
www.gastrohep.com/intlinks/

 

National Digestive Diseases Information Clearinghouse
digestive.niddk.nih.gov/

Site Map | Terms of Use | DanioLabs © .